Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19

Title
Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19
Authors
Keywords
SARS-CoV-2, COVID-19, Natural killer cells, Cytokines, Pulmonary inflammation
Journal
Heliyon
Volume 7, Issue 7, Pages e07635
Publisher
Elsevier BV
Online
2021-07-22
DOI
10.1016/j.heliyon.2021.e07635

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation